Patent details
EP2356090 Title: CRYSTALLINE FORMS OF FINGOLIMOD HCL
Basic Information
- Publication number:
- EP2356090
- PCT Application Number:
- EP2009064891
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097483507
- PCT Publication Number:
- WO2010055028
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF FINGOLIMOD HCL
- French Title of Invention:
- FORMES CRYSTALLINES DE FINGOLIMOD HCL
- German Title of Invention:
- KRISTALLINE FORMEN VON FINGOLIMOD HCL
- SPC Number:
Dates
- Filing date:
- 10/11/2009
- Grant date:
- 05/07/2017
- EP Publication Date:
- 17/08/2011
- PCT Publication Date:
- 20/05/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/07/2017
- EP B1 Publication Date:
- 05/07/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/11/2017
- Expiration date:
- 10/11/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/07/2017
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- MUTZ, Michael
- Address:
- Switzerland (CH)
2
- Name:
- JORDINE, Guido
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 08168865
- Priority Date:
- 11/11/2008
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/137; A61P 37/02; C07C 215/28;
Publication
European Patent Bulletin
- Issue number:
- 201727
- Publication date:
- 05/07/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/03/2018 | Outgoing Correspondence | 1 |